Universal Health Services (UHS)

• Market cap: $10.9B
• 1 day: 3.40%
• 5 days: -5.23%
• 1 month: -8.15%
• 3 months: -12.17%
• 6 months: -28.77%
• Year to date: -7.17%
• 1 year: 1.14%
• 5 years: 64.81%
• 10 years: 36.04%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.

Employees: 99,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

79% more call options, than puts

Call options by funds: $63.7M | Put options by funds: $35.6M

2.89% more ownership

Funds ownership: 88.88% [Q3] → 91.77% (+2.89%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

9% less first-time investments, than exits

New positions opened: 97 | Existing positions closed: 107

10% less repeat investments, than reductions

Existing positions increased: 200 | Existing positions reduced: 221

3% less funds holding

Funds holding: 613 [Q3] → 594 (-19) [Q4]

20% less capital invested

Capital invested by funds: $12.1B [Q3] → $9.67B (-$2.42B) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $200 20% upside
• Avg. target: $220 32% upside
• High target: $249 49% upside

7 analyst ratings

• positive: 3 43%
• neutral: 4 57%
• negative: 0 0%

Baird Michael Ha 27% 1-year accuracy 6 / 22 met price target	34% upside $224	Neutral Downgraded	15 Apr 2025
Guggenheim Jason Cassorla 7% 1-year accuracy 1 / 14 met price target	25% upside $208	Buy Initiated	9 Apr 2025
Morgan Stanley Craig Hettenbach 29% 1-year accuracy 2 / 7 met price target	20% upside $200	Equal-Weight Initiated	26 Mar 2025
Wells Fargo Stephen Baxter 26% 1-year accuracy 8 / 31 met price target	35% upside $225	Overweight Maintained	10 Mar 2025
Stephens & Co. Scott Fidel 46% 1-year accuracy 19 / 41 met price target	34% upside $223	Equal-Weight Maintained	28 Feb 2025